The RBA cannot and won't have any say over fintech rules and regulations, it is consumer lending legislation being adjusted.
The RBA involvement is in the cost of BNPL being forcibly covered by merchants, which is expensive and anti competitive.
- Forums
- ASX - By Stock
- $2 PARTY
The RBA cannot and won't have any say over fintech rules and...
-
- There are more pages in this discussion • 91 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ZIP (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.59 |
Change
-0.110(6.49%) |
Mkt cap ! $1.791B |
Open | High | Low | Value | Volume |
$1.72 | $1.72 | $1.57 | $40.36M | 24.95M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
46 | 202138 | $1.58 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.59 | 55601 | 19 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
44 | 145824 | 1.580 |
28 | 170339 | 1.575 |
45 | 352067 | 1.570 |
18 | 166621 | 1.565 |
22 | 448863 | 1.560 |
Price($) | Vol. | No. |
---|---|---|
1.585 | 175012 | 55 |
1.590 | 163856 | 17 |
1.595 | 265707 | 16 |
1.600 | 340684 | 23 |
1.605 | 247641 | 17 |
Last trade - 15.58pm 15/07/2024 (20 minute delay) ? |
Featured News
ZIP (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online